PG 97-269

Ligand id: 2268

Name: PG 97-269

References
1. Dickson L, Aramori I, McCulloch J, Sharkey J, Finlayson K. (2006)
A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology.
Neuropharmacology, 51 (6): 1086-98. [PMID:16930633]
2. Gourlet P, De Neef P, Cnudde J, Waelbroeck M, Robberecht P. (1997)
In vitro properties of a high affinity selective antagonist of the VIP1 receptor.
Peptides, 18 (10): 1555-60. [PMID:9437716]
3. Gourlet P, Vandermeers A, Vertongen P, Rathe J, De Neef P, Cnudde J, Waelbroeck M, Robberecht P. (1997)
Development of high affinity selective VIP1 receptor agonists.
Peptides, 18 (10): 1539-45. [PMID:9437714]
4. Juarranz MG, Van Rampelbergh J, Gourlet P, De Neef P, Cnudde J, Robberecht P, Waelbroeck M. (1999)
Different vasoactive intestinal polypeptide receptor domains are involved in the selective recognition of two VPAC(2)-selective ligands.
Mol. Pharmacol., 56 (6): 1280-7. [PMID:10570056]